Twist Bioscience

TWST Mid Cap

Healthcare · Diagnostics & Research

Updated: Apr 5, 2026, 17:43 UTC

$50.21

+1.35% today

52W: $23.30 – $57.88

52W Low: $23.30 Position: 77.8% 52W High: $57.88

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

—

Price-to-Earnings

Forward P/E

—

Forward Price/Earnings

P/S Ratio

7.86x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$3.1B

Market Capitalization

Revenue Growth

16.9%

YoY Revenue Growth

Profit Margin

-19.56%

Net profit margin

ROE

-16.79%

Return on Equity

Beta

2.21

Market sensitivity

Short Interest

27.04%

% of float sold short

Avg. Volume

1,325,885

Average daily volume

Valuation Analysis

Signal

N/A

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Strong Buy

9 analysts

Avg. Price Target

$50.44

+0.47% upside

Target Range

$36.00 – $58.00

About the Company

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within di

Sector: Healthcare Industry: Diagnostics & Research Country: United States Employees: 979 Exchange: NMS